Evidence map›Paper›PMID 25484881›Full record

ReviewFrontiers in immunology2014

Myeloid colony-stimulating factors as regulators of macrophage polarization.

Thomas A Hamilton, Chenyang Zhao, Paul G Pavicic, Shyamasree Datta

Registry-linked trialAbstract readReview
In one paragraph

Review in Frontiers in immunology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07511062 (Axatilimab Combined With Decitabine/Venetoclax for the Treatment of TP53-mutated/Deleted AML Patients), which is not on this map. Cited by 122 papers.

0numbers the graph read from it
0cells of the map it votes in
122citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07511062 phase1not yet recruitingnot on this mapstarted 2026, after this paper: background citation

Axatilimab Combined With Decitabine/Venetoclax for the Treatment of TP53-mutated/Deleted AML Patients

TypeinterventionalSponsorNorthside Hospital, Inc.Ran2026 to 2030Enrolled32ConditionsAcute Myeloid Leukemia, TP53 Gene MutationArmsDecitabine, Venetoclax, Axatilimab
3 · Its place in the literature

Who cites it

122 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

62 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Thomas A HamiltonDepartment of Immunology, Lerner Research Institute, Cleveland Clinic Foundation , Cleveland, OH , USA.
Chenyang ZhaoDepartment of Immunology, Lerner Research Institute, Cleveland Clinic Foundation , Cleveland, OH , USA.
Paul G PavicicDepartment of Immunology, Lerner Research Institute, Cleveland Clinic Foundation , Cleveland, OH , USA.
Shyamasree DattaDepartment of Immunology, Lerner Research Institute, Cleveland Clinic Foundation , Cleveland, OH , USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The scope of functional heterogeneity in macrophages has been defined by two polarized end states known as M1 and M2, which exhibit the proinflammatory activities necessary for host defense and the tissue repair activities required for restoration of homeostasis, respectively. Macrophage populations in different tissue locations exist in distinct phenotypic states across this M1/M2 spectrum and the development and abundance of individual subsets result from the local and systemic action of myeloid colony-stimulating factors (CSFs) including M-CSF and GM-CSF. These factors have relatively non-overlapping roles in the differentiation and maintenance of specific macrophage subsets. Furthermore, there is now evidence that CSFs may also regulate macrophage phenotype during challenge. Cell culture studies from multiple laboratories demonstrate that macrophages developed in the presence of GM-CSF exhibit amplified response to M1 polarizing stimuli while M-CSF potentiates responses to M2 stimuli. As a consequence, these factors can be important determinants of the magnitude and duration of both acute and chronic inflammatory pathology and may, therefore, be potential targets for therapeutic manipulation in specific human disease settings.

Indexed as

cytokinesgranulocyte macrophage colony-stimulating factorinflammationmacrophage activationmacrophage colony-stimulating factor

Identifiers

PMID25484881
PMCPMC4240161

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.